Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
BMC Cancer|June 13, 2022
Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept studyBibian M E Tullemans, Sanne L N Brouns, Frauke Swieringa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2019
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with RitonavirVincent A de Weger, Frederik E Stuurman, Stijn L W Koolen, et al.Cancers|August 7, 2021
Effect of Scalp Cooling on the Pharmacokinetics of PaclitaxelLeni van Doorn, Mandy M van Rosmalen, Wendy M van der Deure, et al.Molecular Cancer Therapeutics|November 29, 2023
Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S TransitionStefan A J Buck, Annelies Van Hemelryk, Corrina de Ridder, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 21, 2023
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamideStefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, et al.British Journal of Cancer|April 27, 2018
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patientsSander Bins, Edwin A Basak, Samira El Bouazzaoui, et al.Clinical Pharmacology and Therapeutics|June 25, 2020
Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation ApproachAnna Mueller-Schoell, Lena Klopp-Schulze, Werner Schroth, et al.Therapeutic Drug Monitoring|October 1, 2019
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective StudyStefanie L Groenland, Ruben A G van Eerden, Remy B Verheijen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2020
Intratumoral Comparison of Nanoparticle Entrapped Docetaxel (CPC634) with Conventional Docetaxel in Patients with Solid TumorsFlorence Atrafi, Ruben A G van Eerden, Marte A M van Hylckama Vlieg, et al.European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancerEdwin A Basak, Stijn L W Koolen, Daan P Hurkmans, et al.Pageof 13